Table 2.
Relationship between MAS1 expression and clinicopathological parameters of breast cancer samples
N | MAS1 expression | Weak | Strong | P | ||
---|---|---|---|---|---|---|
None | Trace | |||||
Benign tissue | 21 | 0 | 0 | 2 | 19 | |
DCIS | 10 | 0 | 0 | 3 | 7 | NS |
IDC | 132 | 24 | 50 | 58 | 0 | <0.0001 |
Papillotubular | 35 | 3 | 9 | 23 | 0 | |
Solid-tubular | 55 | 6 | 22 | 27 | 0 | |
Scirrhous | 42 | 15 | 19 | 8 | 0 | 0.0002 |
Grade 1 | 53 | 4 | 18 | 31 | 0 | |
Grade 2 | 37 | 4 | 15 | 18 | 0 | |
Grade 3 | 42 | 16 | 17 | 9 | 0 | 0.0003 |
pT1 | 55 | 1 | 21 | 33 | 0 | |
pT2 | 41 | 7 | 17 | 17 | 0 | |
pT3 | 21 | 8 | 6 | 7 | 0 | |
pT4 | 15 | 8 | 6 | 1 | 0 | <0.0001 |
pN0 | 104 | 1 | 45 | 58 | 0 | |
pN1 | 28 | 23 | 5 | 0 | 0 | <0.0001 |
P-value was calculated by χ2-test. DCIS, ductal carcinomas in situ; IDC, invasive ductal carcinoma; NS, not significant.